Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-09-01
|
| Series: | Therapeutic Advances in Cardiovascular Disease |
| Online Access: | https://doi.org/10.1177/17539447211042714 |
| _version_ | 1818362423919247360 |
|---|---|
| author | Ishwarlal Jialal Naval Vikram |
| author_facet | Ishwarlal Jialal Naval Vikram |
| author_sort | Ishwarlal Jialal |
| collection | DOAJ |
| first_indexed | 2024-12-13T21:32:21Z |
| format | Article |
| id | doaj.art-7ea74a8879574e7b9e1d6fca55e5e8ff |
| institution | Directory Open Access Journal |
| issn | 1753-9455 |
| language | English |
| last_indexed | 2024-12-13T21:32:21Z |
| publishDate | 2021-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Cardiovascular Disease |
| spelling | doaj.art-7ea74a8879574e7b9e1d6fca55e5e8ff2022-12-21T23:30:46ZengSAGE PublishingTherapeutic Advances in Cardiovascular Disease1753-94552021-09-011510.1177/17539447211042714Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?Ishwarlal JialalNaval Vikramhttps://doi.org/10.1177/17539447211042714 |
| spellingShingle | Ishwarlal Jialal Naval Vikram Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? Therapeutic Advances in Cardiovascular Disease |
| title | Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? |
| title_full | Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? |
| title_fullStr | Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? |
| title_full_unstemmed | Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? |
| title_short | Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? |
| title_sort | modulating inflammation to reduce atherosclerotic cardiovascular events should colchicine be part of the therapeutic regimen |
| url | https://doi.org/10.1177/17539447211042714 |
| work_keys_str_mv | AT ishwarlaljialal modulatinginflammationtoreduceatheroscleroticcardiovasculareventsshouldcolchicinebepartofthetherapeuticregimen AT navalvikram modulatinginflammationtoreduceatheroscleroticcardiovasculareventsshouldcolchicinebepartofthetherapeuticregimen |